Literature DB >> 8316504

Characterization of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia.

L Mulgrave1, P V Attwood.   

Abstract

Among 209 isolates of aminoglycoside resistant Enterobacteriaceae isolated from patients attending the Sir Charles Gairdner Hospital in Perth, Western Australia between January 1985 and June 1991, 41 strains demonstrated additional resistance to cefotaxime, ceftriaxone, ceftazidime and aztreonam. Significant synergy was demonstrable between these beta-lactams and clavulanic acid against resistant strains. The beta-lactamase was mediated by a 170 Kb self-transferring plasmid and identified as the SHV-5 type in isoelectric focusing (pl 8.2) and substrate hydrolysis kinetic studies. The findings record the introduction of extended broad-spectrum beta-lactamases to Australia.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8316504     DOI： 10.3109/00313029309068906

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


  9 in total

1.  Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.

Authors:  Y Liu; B J Mee; L Mulgrave
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.

Authors:  Nuno Mendonça; Vera Manageiro; Richard Bonnet; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

3.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.

Authors:  K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; B Cookson; G French
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.

Authors:  Carole Moubareck; Ziad Daoud; Noha I Hakimé; Monzer Hamzé; Nicole Mangeney; Hiam Matta; Jacques E Mokhbat; Raymond Rohban; Dolla Karam Sarkis; Florence Doucet-Populaire
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

Authors:  G L French; K P Shannon; N Simmons
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

Authors:  M Gniadkowski; I Schneider; R Jungwirth; W Hryniewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

8.  Identification and minisequencing-based discrimination of SHV beta-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia.

Authors:  Christopher Howard; Angela van Daal; Gregory Kelly; Jacqueline Schooneveldt; Graeme Nimmo; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 9.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.